logo
Plus   Neg
Share
Email

Best Buy (BBY) Dropped To A New Low Following CEO Resignation

Best Buy (BBY) announced Tuesday that Chief Executive Officer Brian Dunn has resigned from the position and as a director, effective immediately. He leaves the company after serving it for the past 28 years. The company said Director Mike Mikan will replace Dunn as the interim CEO, while it initiates a search for a new CEO.

Best Buy fell sharply in the first 45 minutes of trade Tuesday and slipped further late in the afternoon. The stock ended the session lower by 1.33 at $21.32 on strong volume. Best Buy has been declining for the past 2 weeks and set a new low for the year.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
In the age of social media, it takes mere hours for a company to suffer the backlash of of allegations of racism. For some companies, these incidents have hurt their bottom line and sullied their reputations. For others, they were a blip caused by clumsy if not altogether coincidental missteps. In... BJ's Wholesale Club Holdings Inc., which is planning a return to the public market, has set terms for its planned initial public offering or IPO. In a filing with the U.S. Securities and Exchange Commission, the warehouse club operator said Monday that it plans to offer 37.5 million shares priced between $15 and $17 per share. At the top end of the range, the offering would raise $637.5 million. Shares of Valeant Pharmaceuticals International Inc. are falling more than 6 percent in Monday's trading following news that the U.S. Food and Drug Administration has failed to approve the Canada-based company's Duobrii lotion for the treatment of plaque psoriasis. Ortho Dermatologics, a division of Valeant Pharmaceuticals, said it has received a Complete Response Letter or CRL from the FDA.
Follow RTT